NCT01775722

Brief Summary

Port wine stain Birthmark is a congenital, progressive vascular malformation of human skin. However, even though the pulsed dye laser is considered as the treatment of choice for Port wine stain Birthmark the degree of fading can remain variable and unpredictable after laser treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2012

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

January 14, 2013

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 25, 2013

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2015

Completed
2.7 years until next milestone

Results Posted

Study results publicly available

April 9, 2018

Completed
Last Updated

November 2, 2022

Status Verified

October 1, 2022

Enrollment Period

2.7 years

First QC Date

January 14, 2013

Results QC Date

August 27, 2015

Last Update Submit

October 28, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Percent Change in Blanching of Port Wine Stain

    Port Wine Stain blood volume fractions in the skin before (fB1), and 8 weeks after (fB2) treatment will be determined using the corresponding visual reflectance spectra measured at the treatment sites. The primary outcome, degree of blanching, B, is computed as B = (fB1-fB2)/fB1.

    8 weeks

Study Arms (2)

Pulsed Dye Laser

OTHER

port wine stain treatment using Pulse Dye Laser

Device: Pulsed Dye Laser

Bipolar Radiofrequency&Pulsed Dye Laser

EXPERIMENTAL

Port wine stain using Combined Bipolar Radiofrequency\&Pulsed Dye Laser

Device: Combined Bipolar Radiofrequency&Pulsed Dye Laser

Interventions

port wine stain

Also known as: candela-Laser
Pulsed Dye Laser

Combined Bipolar Radiofrequency\&Pulsed Dye Laser Treatment

Bipolar Radiofrequency&Pulsed Dye Laser

Eligibility Criteria

Age12 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Port Wine Stain suitable for comparison testing
  • Age \> 12 years of age; minor will be accompanied in the room by parents or guardians during laser treatment
  • Apparent good health as documented by medical history
  • Ability to understand and carry out subject instructions

You may not qualify if:

  • History of photodermatoses or skin cancer
  • Any therapy within the previous two months to the proposed port wine stain treatment sites
  • Current participation in any other investigational drug or device evaluation
  • Concurrent use of known photosensitizing drugs
  • Inability to understand and carry out instructions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beckman Laser Institute Medical Clinic

Irvine, California, 92612, United States

Location

MeSH Terms

Conditions

Port-Wine Stain

Interventions

Lasers, Dye

Condition Hierarchy (Ancestors)

Skin AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

LasersOptical DevicesEquipment and SuppliesRadiation Equipment and Supplies

Results Point of Contact

Title
J Stuart Nelson
Organization
University of California, Irvine. Beckamn Laser Institute

Study Officials

  • J. Stuart Nelson, M.D., Ph.D.

    Beckman Laser Institute, UCI

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
J.S.Nelson, MD,PhD,Professor of Surgery and Biomedical Engineering

Study Record Dates

First Submitted

January 14, 2013

First Posted

January 25, 2013

Study Start

December 1, 2012

Primary Completion

August 1, 2015

Study Completion

August 1, 2015

Last Updated

November 2, 2022

Results First Posted

April 9, 2018

Record last verified: 2022-10

Locations